フィルター
5 件の結果が “11611” で取得されました
並べ替える:
アルファベット順(A-Z)
ベストセラー
Agxt KO
製品ID :
C001703
系統:
C57BL/6NCya
状況:
説明:
The AGXT gene, mapping to chromosome 2q37.3, encodes alanine-glyoxylate aminotransferase (AGT), a pyridoxal 5'-phosphate-dependent homotetrameric enzyme predominantly expressed in hepatic peroxisomes [1]. AGT is central to glyoxylate metabolism, catalyzing its transamination to glycine and preventing its oxidation to oxalate [1]. Primary Hyperoxaluria Type 1 (PH1), a rare autosomal recessive disorder affecting approximately 1-3 per million individuals, arises from over 175 identified pathogenic mutations in AGXT. These mutations typically result in deficient or mislocalized AGT, leading to marked overproduction of oxalate [2]. The ensuing hyperoxaluria causes deposition of calcium oxalate in the kidneys, manifesting as nephrolithiasis and nephrocalcinosis, which can progress to end-stage renal disease [3]. In severe cases, systemic oxalosis can occur [4]. Agxt-deficient mice serve as critical preclinical models, faithfully mirroring the biochemical and pathological features of PH1 and enabling the evaluation of diverse therapeutic modalities, including enzyme replacement, substrate reduction, and gene therapy.
The Agxt KO mouse is a gene knockout model created using gene-editing techniques to knock out the coding sequence of the Agxt gene (the homolog of the human AGXT gene) in mice. This model is used to research the pathogenic mechanisms of primary hyperoxaluria and develop related therapeutic strategies.
The AGXT gene, mapping to chromosome 2q37.3, encodes alanine-glyoxylate aminotransferase (AGT), a pyridoxal 5'-phosphate-dependent homotetrameric enzyme predominantly expressed in hepatic peroxisomes [1]. AGT is central to glyoxylate metabolism, catalyzing its transamination to glycine and preventing its oxidation to oxalate [1]. Primary Hyperoxaluria Type 1 (PH1), a rare autosomal recessive disorder affecting approximately 1-3 per million individuals, arises from over 175 identified pathogenic mutations in AGXT. These mutations typically result in deficient or mislocalized AGT, leading to marked overproduction of oxalate [2]. The ensuing hyperoxaluria causes deposition of calcium oxalate in the kidneys, manifesting as nephrolithiasis and nephrocalcinosis, which can progress to end-stage renal disease [3]. In severe cases, systemic oxalosis can occur [4]. Agxt-deficient mice serve as critical preclinical models, faithfully mirroring the biochemical and pathological features of PH1 and enabling the evaluation of diverse therapeutic modalities, including enzyme replacement, substrate reduction, and gene therapy.
The Agxt KO mouse is a gene knockout model created using gene-editing techniques to knock out the coding sequence of the Agxt gene (the homolog of the human AGXT gene) in mice. This model is used to research the pathogenic mechanisms of primary hyperoxaluria and develop related therapeutic strategies.
Stk39-flox
製品ID :
S-CKO-11611
系統:
C57BL/6NCya
状況:
説明:
Stk39 is located on chromosome 2 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Stk39 conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Stk39 is located on chromosome 2 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Stk39 conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Agxt-KO
製品ID :
S-KO-19267
系統:
C57BL/6JCya
状況:
説明:
Agxt is located on chromosome 1 of mice. Nuclease Technology was used to design sgRNA; Agxt knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Agxt is located on chromosome 1 of mice. Nuclease Technology was used to design sgRNA; Agxt knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Agxt-flox
製品ID :
S-CKO-19353
系統:
C57BL/6JCya
状況:
説明:
Agxt is located on chromosome 1 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Agxt conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Agxt is located on chromosome 1 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Agxt conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Alg5-KO
製品ID :
S-KO-11611
系統:
C57BL/6JCya
状況:
説明:
Alg5 is located on chromosome 3 of mice. Nuclease Technology will be used to design sgRNA; Alg5 knockout mice will be obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Alg5 is located on chromosome 3 of mice. Nuclease Technology will be used to design sgRNA; Alg5 knockout mice will be obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Items: 1 to 5 of 5
1
